Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.
Cady RK, Munjal S, Cady RJ, Manley HR, Brand-Schieber E. Cady RK, et al. Among authors: brand schieber e. J Headache Pain. 2017 Dec;18(1):17. doi: 10.1186/s10194-016-0717-7. Epub 2017 Feb 7. J Headache Pain. 2017. PMID: 28176235 Free PMC article. Clinical Trial.
A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.
Munjal S, Brand-Schieber E, Allenby K, Spierings ELH, Cady RK, Rapoport AM. Munjal S, et al. Among authors: brand schieber e. J Headache Pain. 2017 Dec;18(1):31. doi: 10.1186/s10194-017-0740-3. Epub 2017 Mar 1. J Headache Pain. 2017. PMID: 28251391 Free PMC article. Clinical Trial.
DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment.
Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM. Lipton RB, et al. Among authors: brand schieber e. CNS Drugs. 2019 Apr;33(4):375-382. doi: 10.1007/s40263-019-00614-6. CNS Drugs. 2019. PMID: 30877622 Free PMC article. Clinical Trial.
21 results